相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure
Jessica D. Panes et al.
NEURAL REGENERATION RESEARCH (2022)
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis
Sai Zhang et al.
NEURON (2022)
Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS
Xuejun Li et al.
BIOMOLECULES (2022)
Efficacy and Safety Profile of Histone Deacetylase Inhibitors for Metastatic Breast Cancer: A Meta-Analysis
Changjun Wang et al.
FRONTIERS IN ONCOLOGY (2022)
Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice
Oluwamolakun Bankole et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis
Asmita Gyawali et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
Yvonne E. Klingl et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Resveratrol (RV): A pharmacological review and call for further research
Li-Xue Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis
Thibaut Burg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
From Preclinical Stroke Models to Humans: Polyphenols in the Prevention and Treatment of Stroke
Edoardo Parrella et al.
NUTRIENTS (2021)
HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations
Raheem Fazal et al.
EMBO JOURNAL (2021)
The Links between ALS and NF-κB
Emma Kallstig et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
Fabiola De Marchi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Valentina Novak et al.
ANTIOXIDANTS (2021)
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Elisabetta Vegeto et al.
ENDOCRINE REVIEWS (2020)
The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future
Heike J. Wobst et al.
MEDICINAL RESEARCH REVIEWS (2020)
Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
Sida Shen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
Sandra Carrera-Julia et al.
FRONTIERS IN PHYSIOLOGY (2020)
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling
Kallol Dutta et al.
JOURNAL OF NEUROSCIENCE (2020)
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo
Simona Sanna et al.
CELL DEATH & DISEASE (2020)
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease
Arianna Bellucci et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
Surabhi Shukla et al.
FRONTIERS IN PHARMACOLOGY (2020)
The estrogenic activity of resveratrol: a comprehensive review ofin vitroandin vivoevidence and the potential for endocrine disruption
Rani J. Qasem
CRITICAL REVIEWS IN TOXICOLOGY (2020)
Focus on the heterogeneity of amyotrophic lateral sclerosis
Caterina Bendotti et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)
Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia
Mariana Mota et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Edaravone for the treatment of amyotrophic lateral sclerosis
Hiide Yoshino
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease
Seth A. Bennett et al.
TRANSLATIONAL RESEARCH (2019)
Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis
Eva Pigna et al.
EBIOMEDICINE (2019)
The dark side of HDAC inhibition in ALS
Anne-Laurence Boutillier et al.
EBIOMEDICINE (2019)
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence
Amanda M. Dios et al.
MUSCLE & NERVE (2019)
Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model
Elisabeth Rossaert et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol
Young Chan Yun et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Rita Mejzini et al.
FRONTIERS IN NEUROSCIENCE (2019)
Sirtuin signaling in cellular senescence and aging
Shin-Hae Lee et al.
BMB REPORTS (2019)
Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke
Lara Faggi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
Shoubo Chen et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Ruth Chia et al.
LANCET NEUROLOGY (2018)
Amyotrophic Lateral Sclerosis: An Update for 2018
Bjorn Oskarsson et al.
MAYO CLINIC PROCEEDINGS (2018)
Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-κB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1G93A mutation
Xiang Yin et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice
Daniela Buonvicino et al.
NEUROSCIENCE (2018)
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model
Lorenzo Schiaffino et al.
SCIENTIFIC REPORTS (2018)
Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes
Karen Chen et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Amyotrophic lateral sclerosis
Michael A. van Es et al.
LANCET (2017)
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe et al.
LANCET NEUROLOGY (2017)
Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice
Andrea Lapucci et al.
NEUROSCIENCE LETTERS (2017)
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
Wenting Guo et al.
NATURE COMMUNICATIONS (2017)
Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid
Hai-Zhi Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Phenylbutyric Acid: Simple Structure - Multiple Effects
Magdalena Kusaczuk et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis
Mythily Srinivasan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis
Burcin Ikiz et al.
CELL REPORTS (2015)
NF-KappaB in Long-Term Memory and Structural Plasticity in the Adult Mammalian Brain
Barbara Kaltschmidt et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)
NF-κB in innate neuroprotection and age-related neurodegenerative diseases
Annamaria Lanzillotta et al.
FRONTIERS IN NEUROLOGY (2015)
Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
Priyanka Patel et al.
NEUROTHERAPEUTICS (2015)
Endoplasmic reticulum stress is accompanied by activation of NF-κB in amyotrophic lateral sclerosis
T. Prell et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto et al.
LANCET NEUROLOGY (2014)
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Ashley E. Frakes et al.
NEURON (2014)
Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
Jeanine Jochems et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2014)
Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC
Sridurga Mithraprabhu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window
Annamaria Lanzillotta et al.
NEUROBIOLOGY OF DISEASE (2013)
Utility of Capture-Recapture Methodology to Assess Completeness of Amyotrophic Lateral Sclerosis Case Ascertainment
Michael Wittie et al.
NEUROEPIDEMIOLOGY (2013)
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis
Francesco Giribaldi et al.
NEUROPHARMACOLOGY (2013)
Valproic acid and its derivatives enhanced estrogenic activity but not androgenic activity in a structure dependent manner
Sandra Stempin et al.
REPRODUCTIVE TOXICOLOGY (2013)
Histone deacetylases and their role in motor neuron degeneration
Rafael Lazo-Gomez et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Amyotrophic lateral sclerosis: A hormonal condition?
Helene Blasco et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress
Ilenia Sarnico et al.
BRAIN RESEARCH (2012)
Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice
Soyoung Han et al.
BRAIN RESEARCH (2012)
NF-κB: where did it come from and why?
Thomas D. Gilmore et al.
IMMUNOLOGICAL REVIEWS (2012)
Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders
Zacharoula Konsoula et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Robert G. Miller et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: Protection by resveratrol but not riluzole
Matilde Yanez et al.
BRAIN RESEARCH (2011)
Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis
Young-Eun Yoo et al.
EXPERIMENTAL NEUROLOGY (2011)
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways
Vivek Swarup et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology
Mark H. B. Huisman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis
Jing Wang et al.
NEUROSCIENCE LETTERS (2011)
Regulation of neural process growth, elaboration and structural plasticity by NF-κB
Humberto Gutierrez et al.
TRENDS IN NEUROSCIENCES (2011)
AMPK and SIRT1: a long-standing partnership?
Neil B. Ruderman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
The sex ratio in amyotrophic lateral sclerosis: A population based study
Zita R. Manjaly et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Modulation of Synaptic Transmission and Analysis of Neuroprotective Effects of Valproic Acid and Derivates in Rat Embryonic Motoneurons
D. Ragancokova et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Histone Deacetylation and Motor Neuron Degeneration
S. Schmalbach et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
A Single-Dose Resveratrol Treatment in a Mouse Model of Amyotrophic Lateral Sclerosis
Chad D. Markert et al.
JOURNAL OF MEDICINAL FOOD (2010)
Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis
Claas Janssen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury
A. Lanzillotta et al.
CELL DEATH & DISEASE (2010)
Phase 2 study of sodium phenylbutyrate in ALS
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Steven J. Del Signore et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Randomized Sequential Trial of Valproic Acid in Amyotrophic Lateral Sclerosis
Sanne Piepers et al.
ANNALS OF NEUROLOGY (2009)
An in vitro screening cascade to identify neuroprotective antioxidants in ALS
Sian C. Barber et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
LONG-TERM DIETARY ADMINISTRATION OF VALPROIC ACID DOES NOT AFFECT, WHILE RETINOIC ACID DECREASES, THE LIFESPAN OF G93A MICE, A MODEL FOR AMYOTROPHIC LATERAL SCLEROSIS
Cristophe Crochemore et al.
MUSCLE & NERVE (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Necdin regulates p53 acetylation via sirtuin1 to modulate DNA damage response in cortical neurons
Koichi Hasegawa et al.
JOURNAL OF NEUROSCIENCE (2008)
Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model
H. -L. Feng et al.
NEUROSCIENCE (2008)
Activation of NF-κB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP+ toxicity in SK-N-SH cells
I. Sarnico et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
Anamitra Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis
Dohoon Kim et al.
EMBO JOURNAL (2007)
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model
Caroline Rouaux et al.
JOURNAL OF NEUROSCIENCE (2007)
Bim and Noxa are candidates to mediate the deleterious effect of the NF-κB subunit RelA in cerebral ischemia
Ioana Inta et al.
JOURNAL OF NEUROSCIENCE (2006)
The histone deacetylase inhibitor trichostatin A has genotoxic effects in human lymphoblasts in vitro
Andrew J. Olaharski et al.
TOXICOLOGICAL SCIENCES (2006)
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
S Petri et al.
NEUROBIOLOGY OF DISEASE (2006)
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice (vol 93, pg 1087, 2005)
H Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases
MV Simonini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
NF-κB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid β-peptide toxicity
M Pizzi et al.
CELL DEATH AND DIFFERENTIATION (2005)
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides
A Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis
YM Jiang et al.
ANNALS OF NEUROLOGY (2005)
Shaping the nuclear action of NF-κB
LF Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Benefit of valproic acid in suppressing disease progression of ALS model mice
F Sugai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line
M Pizzi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Histone acetylation: a switch between repressive and permissive chromatin - Second in review series on chromatin dynamics
A Eberharter et al.
EMBO REPORTS (2002)
Pharmacological and therapeutic properties of valproate - A summary after 35 years of clinical experience
E Perucca
CNS DRUGS (2002)
分享论文
